CuResponse

About:

Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.

Website: https://www.curesponse.com

Top Investors: aMoon Fund, NCL Technology Ventures

Description:

Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response. The company's technology represents the next step in personalized cancer medicine, moving prediction capabilities beyond genomics and into the world of functional response on living patient cells. The platform preserves the cancer tissue architecture, including the vasculature and immune system, accurately reflecting the cancer growth found in the body. Curesponse’s cutting edge functional platform will match the correct drug to the patient's cancer, improving survival and saving unnecessary medical interventions. The company is harnessing the technology to create a personalized cancer diagnostic assay that can be used to determine the drug response for a specific individual's tumor type.